Rheumatologists must be adequately compensated for managing patients with complex drug therapies and Medicare beneficiaries need access to biologic treatments
Biomarkers in Rheumatoid Arthritis Remain Elusive
Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient
The Rheumatologist as Detective
A case of difficult-to-diagnose Whipple’s disease
2014 ACR/ARHP Annual Meeting: Lung Fibrosis
New drugs, targeted treatments for idiopathic pulmonary fibrosis
New Compound Promotes Recovery from Spinal Cord Injury
Research suggests delivery of protein peptide can restore serotonergic innervation to spinal cord below level of injury; facilitate recovery of locomotor and urinary system function
Hepatitis C Virus Infection Associated with Rheumatoid Arthritis
Research finds patients with chronic HCV infection more likely to develop RA, especially men
Shorter Antibiotic Therapy Effective for Pyogenic Vertebral Osteomyelitis
Six-week treatment regimen returns same results as 12 weeks in recent study, although researchers caution findings may not apply to all patients with vertebral osteomyelitis
Healthcare Software Makes Office Visits More Productive for Patients, Physicians
Rheum-PACER system integrates, synthesizes multiple sources of patient information
Genetic Risk Factors for Rheumatoid Arthritis Merit More Research
New report determines additional risk factors need to be identified, studied before RA heritability can be fully explained
2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
Plus, hydrocodone combination products and brodalumab
- « Previous Page
- 1
- …
- 597
- 598
- 599
- 600
- 601
- …
- 814
- Next Page »